Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.60 | €144.44 | 12.321% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €127.20 | €147.62 | 16.050% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €127.00 | €150.00 | 18.110% |
| Universal Health Services B | 9 | 3 | 2 | 1 | €154.00 | €159.70 | 3.704% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €139.95 | €165.00 | 17.899% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| AbbVie Inc. | 18 | 1 | 2 | 1 | €149.26 | €175.79 | 17.773% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.06 | €201.64 | 36.185% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €203.60 | €204.50 | 0.442% |
| Resmed Inc. | 19 | 0 | 5 | 0 | €203.80 | €207.72 | 1.921% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €153.05 | €215.54 | 40.828% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €186.00 | €237.94 | 27.925% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €195.00 | €247.18 | 26.759% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| HCA Holdings Inc. | 18 | 0 | 2 | 0 | €286.50 | €289.63 | 1.091% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €252.35 | €294.28 | 16.617% |
| Biogen Inc. | 43 | 1 | 3 | 0 | €195.30 | €294.45 | 50.767% |
| Icon plc | 18 | 0 | 6 | 0 | €288.20 | €318.99 | 10.685% |
| Stryker Corp. | 17 | 0 | 4 | 0 | €313.60 | €331.52 | 5.716% |
| Cigna Corp. | 15 | 0 | 1 | 0 | €331.15 | €342.03 | 3.285% |